Clinical Trials Directory

Trials / Completed

CompletedNCT00298909

Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)

Exercise Versus Extended-Release Niacin in Patients With Coronary Heart Disease and Low High-Density Lipoproteins (HDL) Cholesterol: Effect on Lipid Profile and Endothelial Function

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
48 (actual)
Sponsor
University of Leipzig · Academic / Other
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The investigators want to study the relative effects of physical exercise vs. extended-release niacin (lipid-lowering drug) in patients with coronary heart disease and low HDL cholesterol ("good cholesterol") on * lipid profile * endothelial function as measured by ultrasound The endothelium is the inner part of the blood vessels. Impaired endothelial function is known to be associated with atherosclerosis which can ultimately lead to diseases such as stroke, heart attack and others. Endothelial function can be assessed non-invasively by ultrasound. Both interventions mentioned above have been shown to have a beneficial effect on lipid profile and endothelial function. However, the relative effects are unclear.

Detailed description

Comparison of physical exercise vs. extended-release niacin in patients with CAD and low HDL cholesterol (\< 1,03 mmol/L) on lipid profile and endothelial function as measured by flow-mediated dilatation of radial artery. Secondary goals are the assessment of biochemical markers of atherosclerosis, expression of monocyte surface markers, oxidative stress and thrombogenicity.

Conditions

Interventions

TypeNameDescription
BEHAVIORALphysical exercisephysical exercise
DRUGniaspan (extended-release niacin)niaspan (extended-release niacin)
DRUGniacinniacin extended-release
OTHERcontrolcontrol

Timeline

Start date
2006-03-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2006-03-03
Last updated
2012-07-31

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00298909. Inclusion in this directory is not an endorsement.